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Cardiomyocyte excitation–contraction coupling is tightly regulated through coordinated calcium 
release and uptake that is facilitated by two proteins in the sarco/endoplasmic reticulum (SR/ER) 
membrane, the ryanodine receptor (Ryr), and the sarco/endoplasmic reticulum Ca2+-ATPase 
(SERCA), respectively. Dysregulated calcium handling is a hallmark in cardiac dysfunction (1–3). 
Our understanding of the molecular mechanisms that underlie these calcium handling anomalies 
and their precise role in the associated pathologies remains incomplete. A growing body of indirect 
evidence has implicated a role for redox signaling, and the mitochondria have been thought to be 
the primary source of reactive oxygen species (ROS) (4–10). Research in this area suggests that ROS 
generated from the mitochondria alters the redox milieu around the SR/ER–mitochondria interface 
causing excessive oxidation of the cysteine residues in Ryr and SERCA that results in an increase 
in calcium release and decrease in uptake, respectively, thus depleting the SR/ER Ca2+ stores and 
causing dysregulated downstream signaling (4–10). However, many questions remain unanswered, 
and the source of the ROS has not been directly validated.
Mitochondria and SR/ER are in close apposition and the interface, commonly known as the 
mitochondrial-associated ER membrane (MAM), is believed to act as the focal point for this signal-
ing. Our knowledge of calcium signaling in cardiac pathologies, where ER and oxidative stresses 
are predominant (11–14), suggests that calcium may, in fact, be the cause, rather than the effect, 
of mitochondrial ROS. This implies that calcium overload signals mitochondria to produce lethal 
levels of ROS. Therefore, do alternative sources of ROS initiate the redox imbalance that causes 
calcium dysregulation? In this article, we present data that suggest that, in addition to mitochon-
drial ROS, ROS originating in the ER may indeed explain gaps existent in the field cardiovascular 
pathophysiology.
ER ROS AnD CALCiUM SiGnALinG AT THE MAMs
The ER is a primary site of protein synthesis and posttranslational processing. The concomitant 
production of hydrogen peroxide (H2O2), as a byproduct of the Ero1α-PDI protein folding pathway 
and a high glutathione disulfide:glutathione (GSSG:GSH) ratio keeps the SR/ER in a slightly oxida-
tive state (15). The redox state of the ER is critical for the folding process and factors that lead to the 
accumulation of the oxidizing equivalents in the ER give rise to mis/unfolded polypeptides, a condi-
tion known as ER stress. ER stress initiates the activation of the unfolded protein response (UPR). 
The UPR increases the capacity of the protein folding machinery resulting in the production of more 
oxidative equivalents, and further deteriorating the redox state. The cell handles the exacerbated 
stress by inhibiting protein synthesis and activating the ER-associated degradation (ERAD) pathway 
to remove the terminally misfolded proteins (16). An important feature of the stressed condition 
is the release of calcium from the ER by the opening of calcium channels, including the ryanodine 
receptor and inositol-3-phosphate receptor (IP3R) (17).
Regulated calcium release from the SR/ER is essential for several cellular processes including 
muscle contraction. Intra SR/ER calcium also plays an important role in ER chaperone function 
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in protein folding. To maintain calcium homeostasis calcium is 
returned to the SR/ER through SERCA. During pathophysiologi-
cal conditions, both the release and uptake of calcium from the 
ER are dysregulated, resulting in enhanced calcium release (18, 
19). Much of the released calcium is taken up by the mitochon-
dria. Mitochondrial calcium overload can lead to mitochondrial 
dysfunction and the initiation of a cascade of pro-apoptotic 
events (20). The checkpoint for this phenomena lies on the 
MAMs and the calcium handling proteins, Ryr (excitable cells) 
(21) and IP3R (non-excitable cells) (20) on the ER, and VDAC 
on the outer mitochondrial membrane (20) have been shown to 
reside at this interface where they function to mediate in the facile 
transfer of calcium from the SR/ER to mitochondria. Calcium 
within the mitochondria generates superoxide that is presumed 
to be the marker for oxidative stress (22). This led to the design 
of mitochondrial targeted antioxidant therapies; however, these 
therapies have largely failed in the clinical trials relating to car-
diovascular disorders (23, 24).
pHYSiOLOGiCAL pRODUCTiOn OF 
MiTOCHOnDRiAL AnD ER ROS
Mitochondria are traditionally believed to be an important source 
of ROS, and the role of mitochondrial ROS in mediating cardiac 
pathophysiology has been shown in numerous studies (25, 26). 
However, in the context of the myocardium, it is not clear that 
mitochondrial ROS actually cause calcium dysregulation in the 
SR/ER. The proximal mitochondrial ROS, superoxide ( )O2
−  is pro-
duced when the electrons leak while passing through the electron 
donors in the complex I and complex III of the mitochondrial 
respiratory chain. Superoxide, being unstable and short lived, is 
catalytically dismutated into H2O2 by the manganese superoxide 
dismutase (MnSODs) in the mitochondrial matrix; this form can 
readily move across the biological membranes to oxidize various 
targets. As noted by Murphy (27), two factors primarily deter-
mine the rate of O2
⋅− production by mitochondria; the enzyme 
concentration carrying the electron donor (NADH, NADPH, 
and CoQH2); and the proportion of the electron donor present in 
the redox form that can react with O2 to generate O2
−. The latter 
may be governed by the local environment, such as the proton 
motive force, mitochondrial ATP synthesis, and other parameters 
including pH, O2 concentration, mutation, posttranslational 
modifications, etc. Similarly, the oxidizing power of H2O2 is kept 
low by the action of the cellular enzymes. Besides catalase, which 
was the first enzyme to be discovered that scavenges H2O2 and is 
not abundant in mitochondria (28, 29), another enzyme system 
called the thioredoxin (Trx) system has gained importance with 
respect to the scavenging of mitochondrial H2O2. The Trx system 
consists of Trx, NADPH-dependent Trx reductase, and peroxire-
doxins (Prx), and in an electron relay, the Trx reductase transfers 
electrons from NADPH to Trx which then transfers them to Prx 
to convert H2O2 into H2O (30–32). Most importantly, Trx2 has 
been shown to buffer mitochondrial H2O2 in cardiomyocytes (33). 
Presumably, under physiological conditions, there is minimal 
ROS production by mitochondria, but this may be enhanced by 
pathophysiological conditions such as myocardial ATP depletion 
and high proton motive force that results in decreased muscle 
contractility and may leave the electron donor in a redox form that 
favors ROS generation. A recent study by Santulli et al. (10) dem-
onstrated that in heart failure, the mitochondrial calcium overload 
mediated through the leaky Ryr2 increases the ROS production 
in mitochondria which subsequently oxidizes the Ryr2, thereby 
enhancing the SR/ER Ca2+ leak. This viscous cycle of Ca2+ leak-
age, calcium overload, and ROS generation completely paralyzes 
cardiac contractility. Noteworthy, the signal for such phenomena 
originates upstream when calcium dysregulation has already 
begun from the SR/ER, suggesting that mitochondrial ROS are 
merely a result of impaired calcium release under these scenarios. 
Moreover, ample evidence indicates that mitochondrial ROS have 
a far greater role in bringing oxidative damage to the cell, and in 
most pathologies, such as neurodegenation, aging, and diabetes 
(34–36), this initiates apoptosis. An interesting observation made 
by Leadsham et al. (37) demonstrated that increased ROS levels 
following mitochondrial dysfunction are mainly due to the O2
⋅−  
production from the NADPH oxidase, Yno1p on the ER surface 
in yeast. While this study lacks mechanistic details (38), it does 
suggest that mitochondria may not be the lead source of ROS 
even when it is dysfunctional.
On the other hand, considering ER ROS, H2O2 is a prerequisite 
for oxidative folding and is a regular and direct byproduct of the 
process. Evidence shows that the H2O2 produced by the PDI-Ero1α 
pathway is locally detoxified by another enzyme – PrxIV. H2O2 
oxidizes the two cysteine residues in PrxIV, after which PrxIV 
oxidizes the PDI(red) during the oxidative folding of proteins. It has 
been postulated that PrxIV helps to maintain the redox balance in 
the ER lumen by preventing H2O2 accumulation. However, under 
conditions of UPR activation, excessive H2O2 may hyperoxidize 
PrxIV, inhibiting its activity, thereby disturbing the redox balance 
(39). Consistent with this observation, it is intuitive that H2O2 can 
also oxidize other proteins in the ER.
REDOX REGULATiOn OF CALCiUM 
HAnDLinG pROTEinS
Interestingly, ER stress signals result in enhanced calcium release 
and inhibition of Ca2+ uptake into the ER. SERCA, IP3R, and 
Ryr channels are all subjected to redox regulation. The activity 
of SERCA is regulated by S-glutathionylation, and evidence 
shows that SERCA is inhibited by the ROS-mediated S-oxidation 
of the conserved Cys 674 (40). Likewise, ROS alters the bind-
ing of inositol 1,4,5-trisphosphate (IP3) to the IP3R and affect 
its activity (41). For Ryr calcium channels, multiple cysteine 
residues are redox regulated. Sun et al. (42) identified the nature 
of 93/100 cysteine residues in the skeletal muscle isoform of 
ryanodine receptor (Ryr1). The redox-regulated Cys residues 
were categorized by their dependency toward muscle oxygen 
tension. It was found that 13 Cys residues are subjected to pO2-
dependent S-oxidation. Furthermore, eight Cys residues were 
found to be oxidized at high versus low pO2 when NADPH was 
supplemented to enhance NADPH oxidase 4 (NOX4) activity. 
Importantly, these redox-regulated Cys residues were shown 
to localize to the binding regions of two interacting partners 
of Ryr1 – FKBP12 and calmodulin, which, when bound to Ryr 
favors a closed channel configuration. In a separate study, Sun 
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et al. (43) demonstrated that NOX4 colocalizes with Ryr1 on the 
SR/ER membrane and directly generates H2O2 that is responsible 
for oxidizing the set of redox regulatory Cys residues in Ryr1. 
This evidence adds NOX4 as a yet another direct source of H2O2 
in the SR/ER. The cardiac Ryr (Ryr2) contains 89 Cys residues, it 
has been shown that hyperoxidation of the channel increases its 
open probability, which makes the channel leaky (44), a patho-
physiological condition predominant in heart failure. However, 
the identities of the redox-regulated Cys residues are yet to be 
determined. Another enzyme, calmodulin-dependent protein 
kinase II (CaMKII), has been shown to play a preeminent role 
in regulating the activity of both Ryr2 and SERCA. CaMKII 
inhibits phospholamban by phosphorylating it at Thr17, which 
activates SERCA and increases Ca2+ uptake into SR/ER (45). 
Similarly, CaMKII phosphorylates Ryr2 at Ser2814 and possibly 
at Ser2808 and induces both diastolic SR Ca2+ leak and sensitizes 
Ryr2 to Ca2+-induced Ca2+release during excitation–contraction 
coupling (45). Interestingly, oxidation of CaMKII has been linked 
to heart failure. It has been shown that H2O2-mediated oxidation 
of pair of methionine residues (Met281/282) in CaMKII activates 
the kinase activity and phosphorylates Ryr2, rendering it leaky 
and thereby depleting the SR Ca2+ content. However, methionine 
oxidation of CaMKII results from oxidative stress generated from 
mitochondrial H2O2 and subjects’ cardiomyocytes to apoptosis 
during heart failure (46).
COnCLUSiOn
The potential role of the ER in the induction of calcium dysregula-
tion adds a new dimension to the already established role of ROS 
from the mitochondria. It is plausible that the skewed production 
of ROS can begin well before the mitochondrial mediation dur-
ing the adaptive phase of UPR when the protein folding capacity 
is enhanced that alters the redox states of Ryr and SERCA and 
triggers an aberrant calcium release and uptake, respectively. 
Moreover, the ROS thus generated would better serve both the 
temporal and spatial aspects in oxidizing the Cys residues of RyR 
and SERCA (Figure 1). Future research will directly test the role 
of redox signaling initiating from the SR/ER; this could lead to 
the identification of novel upstream targets for the development 
of new, more efficient therapies.
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FiGURE 1 | production of reactive oxygen species (ROS) by the ER and mitochondria. (A) The current view is that the calcium overload in mitochondria (1), 
generates ROS by activating Kreb cycle (2), leading to the oxidation of Ryr and SERCA (3), resulting in increased calcium release through Ryr and reduced calcium 
uptake from SERCA (4), the released calcium is taken up by mitochondria (5), resulting in increased ROS production. (B) We hypothesize that activation of UPR in 
response to ER stress results in the generation of ROS (1) and leads to the oxidation and dysregulation of Ryr and SERCA (2), enhanced calcium release from the 
ER leads to mitochondrial calcium uptake (3), resulting in enhanced mitochondrial ROS production and the release of Cyt c into the cytosol, and the initiation of 
apoptosis (4), excessive mitochondrial ROS can further exacerbate impaired calcium signaling through Ryr and SERCA (5). Abbreviations: Ryr, ryanodine receptor; 
SERCA, sarco/endopiasmic reticulum Ca2+ ATPase; VDAC, voltage-dependent anion channel; MCO, mitochondrial calcium uniporter; PTP, permeability transition 
pore; Cyt c, cytochrome c; MAM, mitochondrial-associated ER membrane; ROS, reactive oxygen species.
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